[New data on Gaucher's disease].
Stirnemann
J
J
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives / Q000627:therapeutic use; D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005776:Gaucher Disease / Q000145:classification / Q000188:drug therapy / Q000235:genetics; D005962:Glucosylceramidase / Q000627:therapeutic use; D006801:Humans; D010641:Phenotype; D011994:Recombinant Proteins / Q000627:therapeutic use
D004791:Enzyme Inhibitors; D011994:Recombinant Proteins; D017485:1-Deoxynojirimycin; C059896:miglustat; D005962:Glucosylceramidase; C090568:imiglucerase